精准疾病管理：长新冠慢性肺损伤的预后生物标志物
Precision disease management: prognostic biomarker for chronic lung damage in long COVID.
作者信息
Oo Adrian, Chu Justin Jang Hann
机构信息
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore, Singapore.
Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
出版信息
ERJ Open Res. 2024 Dec 2;10(6). doi: 10.1183/23120541.00647-2024. eCollection 2024 Nov.
Abstract
摘要
https://bit.ly/3Ccxozg. （此为网址，无法准确完整翻译其内容，保留原文形式）
相似文献
1
Precision disease management: prognostic biomarker for chronic lung damage in long COVID.精准疾病管理：长新冠慢性肺损伤的预后生物标志物
ERJ Open Res. 2024 Dec 2;10(6). doi: 10.1183/23120541.00647-2024. eCollection 2024 Nov.
2
Matrix metalloprotease-7 is associated with post-COVID-19 persistent lung abnormalities.基质金属蛋白酶-7与新冠病毒感染后持续的肺部异常有关。
ERJ Open Res. 2024 Dec 2;10(6). doi: 10.1183/23120541.00266-2024. eCollection 2024 Nov.
3
Coronavirus Disease 2019: Quick Diet and Nutrition Guide for Patients With Chronic Kidney Disease.新型冠状病毒肺炎：慢性肾脏病患者的快速饮食与营养指南。
J Ren Nutr. 2021 Jan;31(1):39-42. doi: 10.1053/j.jrn.2020.08.008. Epub 2020 Aug 18.
4
Genomic classifier: biomarker for progression in interstitial lung disease.基因组分类器：间质性肺疾病进展的生物标志物。
ERJ Open Res. 2025 May 6;11(3). doi: 10.1183/23120541.01013-2024. eCollection 2025 May.
5
Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19.新冠后长期新冠及肺部后遗症患者中SARS-CoV-2 T细胞反应的持续性
ERJ Open Res. 2023 May 9;9(3). doi: 10.1183/23120541.00020-2023. eCollection 2023 May.
6
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19.用于治疗与新型冠状病毒肺炎相关的严重急性呼吸窘迫综合征的体外膜肺氧合
Breathe (Sheff). 2021 Mar;17(1):200278. doi: 10.1183/20734735.0278-2020.
7
Home monitoring of lung mechanics by oscillometry before, during and after severe COVID-19 disease: a case study.通过振荡法对重症 COVID-19 疾病患者在患病前、患病期间及康复后的肺力学进行家庭监测：一项病例研究。
ERJ Open Res. 2023 Apr 11;9(2). doi: 10.1183/23120541.00480-2022. eCollection 2023 Mar.
8
Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era.全球医疗服务提供者对COVID-19时代间质性肺疾病患者电子健康的经验与看法。
ERJ Open Res. 2021 Aug 31;7(3). doi: 10.1183/23120541.00405-2021. eCollection 2021 Jul.
9
Pre-COVID-19 lung function and other risk factors for severe COVID-19 in first responders.新冠疫情前急救人员的肺功能及其他严重新冠疫情风险因素。
ERJ Open Res. 2021 Jan 25;7(1). doi: 10.1183/23120541.00610-2020. eCollection 2021 Jan.
10
Need for sex-stratified reference values for exhaled nitric oxide as biomarker in chronic cough.慢性咳嗽中作为生物标志物的呼出一氧化氮的性别分层参考值的必要性。
ERJ Open Res. 2024 Jul 29;10(4). doi: 10.1183/23120541.00202-2024. eCollection 2024 Jul.
本文引用的文献
1
Long-COVID Prevalence and Its Association with Health Outcomes in the Post-Vaccine and Antiviral-Availability Era.疫苗接种和抗病毒药物可及时代的长期新冠患病率及其与健康结局的关联
J Clin Med. 2024 Feb 21;13(5):1208. doi: 10.3390/jcm13051208.
2
Diffusing capacity as an independent predictor of acute exacerbations in chronic obstructive pulmonary disease.弥散能力作为慢性阻塞性肺疾病急性加重的独立预测指标
Sci Rep. 2024 Feb 5;14(1):2936. doi: 10.1038/s41598-024-51593-8.
3
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.活动性长新冠伴有血栓炎症迹象的持续补体失调。
Science. 2024 Jan 19;383(6680):eadg7942. doi: 10.1126/science.adg7942.
4
Post-COVID-19 pulmonary fibrosis: An ongoing concern.新冠病毒感染后肺纤维化：持续受到关注。
Ann Thorac Med. 2023 Oct-Dec;18(4):173-181. doi: 10.4103/atm.atm_7_23. Epub 2023 Oct 17.
5
VEGF-A plasma levels are associated with impaired DLCO and radiological sequelae in long COVID patients.血管内皮生长因子 A 的血浆水平与长新冠患者的 DLCO 受损和影像学后遗症有关。
Angiogenesis. 2024 Feb;27(1):51-66. doi: 10.1007/s10456-023-09890-9. Epub 2023 Aug 1.
6
Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications.与新冠后并发症肺部表现相关的氧化生物标志物
J Clin Med. 2023 Jun 25;12(13):4253. doi: 10.3390/jcm12134253.
7
The WHO declares COVID-19 is no longer a public health emergency of international concern: benefits, challenges, and necessary precautions to come back to normal life.世界卫生组织宣布新冠疫情不再构成国际关注的突发公共卫生事件：恢复正常生活的益处、挑战及必要预防措施。
Int J Surg. 2023 Sep 1;109(9):2851-2852. doi: 10.1097/JS9.0000000000000513.
8
Biomarkers in long COVID-19: A systematic review.新冠长期症状中的生物标志物：一项系统综述。
Front Med (Lausanne). 2023 Jan 20;10:1085988. doi: 10.3389/fmed.2023.1085988. eCollection 2023.
9
The NIH-led research response to COVID-19.美国国立卫生研究院牵头针对新冠疫情的研究应对措施。
Science. 2023 Feb 3;379(6631):441-444. doi: 10.1126/science.adf5167. Epub 2023 Feb 2.
10
Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease.乳酸脱氢酶升高反映了 COVID-19 肺炎在胸部 CT 上的进展，并预测了随后的严重疾病。
Sci Rep. 2023 Jan 18;13(1):1012. doi: 10.1038/s41598-023-28201-2.
Zotero 插件